Navigation Links
Fuisz Pharma LLC Announces Patent Filing for Novel System and Method to Obtain Blood for Diagnostic Analysis Using a Lancet or Needle Puncture
Date:1/14/2014

MIAMI, Jan. 14, 2014 /PRNewswire/ -- Fuisz Pharma announced that it has filed a new patent application with the United States Patent & Trademark Office for a state of the art system, method and kit to obtain blood samples from a finger stick. The blood obtained is greater in volume and includes a system of management of capillary tubes and of obtaining refreshed capillary field blood that more closely approximates the diagnostic gold standard, venous blood, than traditional finger stick draws do.

Joseph Fuisz, managing member for Fuisz Pharma LLC, commented: "This is an exciting breakthrough in an area that had been static for far too long.  It enables a substantial increase in harvested blood draw from a single stick.  We feel this invention will be useful if the finger stick becomes commonplace in broad-based blood analytics."

Richard Fuisz M.D. added: "I am old enough and experienced enough in life to know that horses precede carts. If in the future blood diagnostics is based broadly in many parameters from a finger stick, then a better way needed to be invented to increase the yield of blood volume and improve the blood quality from a finger stick. We feel we have not just the better way but the essential way to accomplish the task."

Fuisz Pharma LLC is a private pharmaceutical technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, as well as independently developing extruded sheet technology, and have extensive experience working with big and specialty pharma.  Fuisz Pharma is also active in diagnostic systems.  Fuisz Pharma has its headquarters in Miami. www.fuisz.com.


'/>"/>
SOURCE Fuisz Pharma LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Fuisz Pharma Announces Intent to Divest Strategic Patent for Detection of Opioid Abuse; Seeks Offers for Patent through May 2013
2. Fuisz llc Announces Induction of Richard C. Fuisz, M.D., into Georgetown Universitys 1789 Society.
3. Fuisz Pharma Announces Patent Allowance For New Tablet And Caplet Shapes That Promote Rapid, Reliable Esophageal Transit
4. Isis Pharmaceuticals to Receive $7.5 Million from Alnylam
5. Upsher-Smith Honors 42 Pharmacists Nationwide For Excellence In Innovation
6. ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer
7. Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance
8. Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
9. Avanir Pharmaceuticals Pre-announces Preliminary Fiscal 2014 First Quarter Financial Information
10. Big pharmas need to tap M&A for growth will persist in 2014, while dealmaking landscape becomes more competitive
11. Mezzion Pharma Announces Collaboration With New England Research Institutes To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
(Date:4/18/2017)... 2017 Research and Markets has announced ... Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... revenues as well as growth in the number of unit ... to market participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier ... position. The former overall number one pick in the 2001 NFL Draft, to the ... the record for the most career rushing yards by a quarterback (6,109) and the ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin ... of Education Research Award. The award honors scholars exemplary in their capacity to ... scholar who has demonstrated the capacity to deepen the public’s understanding and appreciation ...
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... that they are seeking public support to bring their novel lifesaving device for ... wearable device packed with medical-grade sensors, specially designed to read a child’s vital ...
Breaking Medicine News(10 mins):